1-3 of 3
Florence Cymbalista, Pr
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interest of Early Determination of Bone Marrow MRD by a Sensitive 6-Color Flow Cytometry in the Evaluation of Response: The Experience of the CLL2007FMP, An Intergroup Phase III Randomized Multicentric Trial Comparing Fludarabine Cyclophosphamide (FC) and Rituximab (FCR) Versus FC and MabCampath (FCCam) in Previously Untreated B-Chronic Lymphocytic Leukemia Patients

Remi Letestu, MD, Stéphane Leprêtre, MD, Christine Arnoulet, Pharm. D., Lucile Baseggio, Lydia Campos, MD, PhD, Bernard Chatelain, Bernard Drenou, MD, PhD, Marie-Christine Jacob, Eric Legac, Magali Le Garff-Tavernier, Nelly Robillard, Michel Ticchioni, Roselyne Delepine, Vincent Levy, MD, Sandrine Katsahian, Veronique Leblond, Florence Cymbalista, Pr, Pierre Feugier, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1797.
https://doi.org/10.1182/blood.V118.21.1797.1797
Published: 2011
Journal Articles

Consolidation Therapy with Subcutaneous Alemtuzumab After Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65–70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): Final Results of a Phase II Study From the FCGCLL/WM,

Alain Delmer, MD, Olivier Tournilhac, MD, PhD, Stéphane Leprêtre, MD, Bruno Cazin, MD, Pierre Feugier, MD, PhD, Brigitte Dreyfus, MD, Beatrice Mahe, Michel Leporrier, MD, Anne-Sophie Michallet, MD, Arnaud Jaccard, Marine Divine, MD, Vincent Levy, MD, Florence Cymbalista, Pr, Remi Letestu, MD
Journal: Blood
Blood (2011) 118 (21): 3900.
https://doi.org/10.1182/blood.V118.21.3900.3900
Published: 2011
Journal Articles

Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Interim Analysis of a Phase II Study of the GCLLSG and fcgcll/MW

Stephan Stilgenbauer, Prof. Dr. med, Florence Cymbalista, Pr, Véronique Leblond, Pr, Alain Delmer, MD, Dirk Winkler, MD, Andreas Bühler, Dr. med., Thorsten Zenz, Prof. Dr. med., Silja Mack, Raymonde Busch, Dipl.-Math., Axel Hinke, Dr., Sylvain Choquet, MD, Caroline Dartigeas, Dr., Bruno Cazin, Dr., Olivier Tournilhac, MD, PhD, Michael Rieger, MD, Jürgen Alt, Dr. med, Martin Sökler, Dr. med, Johannes Schetelig, MD, Peter Dreger, Prof. Dr. med., Michael Hallek, MD, Hartmut Döhner, Prof. Dr. med.
Journal: Blood
Blood (2011) 118 (21): 2854.
https://doi.org/10.1182/blood.V118.21.2854.2854
Published: 2011